Menopause-related mood swings affect up to 70% of women during the transition. Learn why estrogen and progesterone shifts trigger irritability, anxiety, and emotional volatility, plus evidence-based treatments.
Evidence-informed guidance for partners, family, and friends supporting someone through menopause: understanding the biology, communicating well, encouraging medical care, and knowing when symptoms need urgent attention.
Evidence-based analysis of whether 14 to 16 hour intermittent fasting is required for metabolic, weight, and hormonal benefits, with specific guidance for women on HRT.
Coronary artery calcium (CAC) scoring can help menopausal women quantify hidden heart disease risk. Learn who should get tested, what scores mean, and how results shape treatment.
Menopause-related UTIs are common and treatable. Learn how vaginal estrogen, D-mannose, lifestyle changes, and prophylactic strategies reduce recurrent urinary tract infections after menopause.
The average age for natural menopause in the U.S. Is 51. Learn what factors shift that timeline, how perimenopause symptoms begin years earlier, and how telehealth platforms like Alloy Health compare for HRT access.
Vascular aging accelerates after menopause due to estrogen decline. Learn how arterial stiffness, endothelial dysfunction, and hormonal shifts raise cardiovascular risk, plus evidence-based assessment and management strategies.
A breakdown of the FDA's updated guidance on hormone replacement therapy, including who qualifies, approved formulations, risks, benefits, and what changed since the WHI trial.
A clinical review of perimenopause supplements with real trial data. Covers black cohosh, phytoestrogens, magnesium, vitamin D, omega-3s, and adaptogens backed by published research.
Menopause alters how your body processes alcohol, leading to worse and longer hangovers. Learn the hormonal science behind increased alcohol sensitivity and what you can do about it.
Menopause-related anxiety affects up to 51% of women during the transition. Learn the hormonal causes, evidence-based treatments, and when to seek help for perimenopausal and menopausal anxiety.
A practical guide for partners, family members, and friends supporting someone through menopause, covering symptom awareness, communication strategies, medical options, and lifestyle adjustments.
Menopause musculoskeletal syndrome causes joint pain, stiffness, and tendon changes in up to 70% of midlife women. Learn what drives it, how estrogen loss affects connective tissue, and which treatments have clinical evidence.
A detailed comparison of Zepbound (tirzepatide) pricing against Wegovy, Saxenda, and other weight-loss medications, with trial data showing how efficacy stacks up dollar for dollar.
Zepbound (tirzepatide) was FDA-approved on November 8, 2023, after over a decade of incretin research and the SURMOUNT-1 trial showing 20.9% weight loss.
Medicare Advantage plans do not cover Zepbound (tirzepatide) for weight loss under current CMS rules. Learn why coverage is denied, how to appeal, and what alternatives exist.
Evidence-based guide to safely stopping zoledronic acid (Reclast), including drug holidays, fracture risk monitoring, bone turnover markers, and when to restart therapy.
Ambien's MOA involves selective binding to alpha-1 GABA-A receptors, boosting chloride influx for targeted sedation within 15 to 30 minutes, half-life ~2.5 hours.
A clinician-grade review of zolpidem (Ambien) off-label uses, including disorders of consciousness, tinnitus, movement disorders, and more, with evidence grades and cited trials.
Find out whether Medicare Part D covers Adderall XR (mixed amphetamine salts), what you can expect to pay at each coverage phase, and how to reduce out-of-pocket costs through generics, prior authorization, and manufacturer programs.
Complete guide to the Praluent (alirocumab) manufacturer copay program from Regeneron and Sanofi, including eligibility, savings amounts, insurance tips, and alternative ways to afford PCSK9 inhibitor therapy.
How to access alprostadil (Caverject, MUSE) at reduced or no cost through manufacturer programs, compounding pharmacies, state assistance, and insurance strategies.
Find out how to get amlodipine for free or at reduced cost through patient assistance programs, manufacturer discounts, $4 generics, and state programs. Updated for 2026.
Complete guide to the AndroGel manufacturer copay program from AbbVie, including eligibility rules, savings card details, insurance tips, and alternative cost-reduction strategies for testosterone gel.
A detailed guide to getting AndroGel covered under Medicare Advantage plans, including copay estimates, prior authorization requirements, generic alternatives, and patient assistance programs.
Compare AndroGel assistance, generic testosterone gel, pharmacy quotes, insurance coverage, Medicare Extra Help, and VA access options.
Step-by-step guide to obtaining AndroGel or generic testosterone gel through VA pharmacy benefits, including formulary status, prior authorization requirements, and cost-saving alternatives for veterans.
A clinical guide to AOD-9604 patient assistance programs, compounding pharmacy pricing, insurance realities, and practical strategies for low-income patients seeking affordable access in 2026.
A clinical guide to BPC-157 compounded equivalents, including 503A pharmacy sourcing, typical costs, insurance realities, and how to evaluate peptide quality and safety.
BPC-157 is not covered by Medicare Advantage plans. Learn why this compounded peptide falls outside Part D formularies, what it costs out of pocket, and how to reduce your spending.
A guide to Vyleesi (bremelanotide) patient assistance programs, manufacturer coupons, compounding options, and insurance coverage strategies for low-income patients with HSDD.
A step-by-step guide to obtaining Vyleesi (bremelanotide) coverage through the VA healthcare system, including non-formulary request procedures, clinical justification strategies, and alternative cost-saving pathways.
How Medicare Advantage plans cover tadalafil (generic Cialis), what you'll pay out of pocket, and practical strategies to reduce your cost in 2026.
CJC-1295 is not covered by Medicare Advantage plans. Learn why, what it costs out of pocket, and how to reduce the price of compounded CJC-1295 modified GRF in 2026.
Farxiga's manufacturer copay program can cut costs to $0 monthly for insured patients; uninsured or Medicare patients may qualify for free drug via AZ&Me.
Complete guide to Farxiga (dapagliflozin) Medicare Part D coverage in 2026, including the new negotiated price, out-of-pocket caps, copay assistance, and strategies to reduce your costs.
Complete guide to the Amgen FIRST STEP copay card for Prolia (denosumab), including eligibility, savings amounts, alternative assistance programs, and insurance coverage strategies for 2026.
Complete guide to Medicare Part D coverage for Prolia (denosumab) injections, including formulary tiers, copay estimates, manufacturer assistance programs, and alternative savings strategies for 2026.
A complete guide to getting Prolia (denosumab) through the VA healthcare system, including formulary status, prior authorization steps, copay tiers, and alternative savings programs for veterans.
Learn how Medicare Advantage plans cover Trulicity (dulaglutide), typical copay tiers, prior authorization requirements, and strategies to reduce your cost in 2026.
How to access dutasteride (Avodart) affordably through patient assistance programs, manufacturer coupons, generic options, and insurance coverage strategies.
How veterans can access dutasteride (Avodart) through the VA healthcare system. Covers formulary tier, copay structure, non-formulary exceptions, and alternatives for reducing out-of-pocket cost.
A complete guide to Jardiance patient assistance programs, manufacturer coupons, and low-income options for empagliflozin in 2026. Covers Boehringer Ingelheim savings cards, PAPs, Medicare Extra Help, and state programs.
A clinical guide to compounded enclomiphene citrate: how compounding works, what it costs, how it compares to brand-name options, insurance coverage, and how to get enclomiphene cheaply and safely.
Learn about enclomiphene citrate copay assistance, compounding pharmacy pricing, insurance coverage strategies, and patient savings programs available in 2026.
Enclomiphene citrate is not covered by Medicare Part D. Learn why, what it costs out of pocket, and how to access affordable compounded enclomiphene through alternative pathways.
How to afford enclomiphene citrate on a limited budget: compounding pharmacy pricing, patient assistance programs, insurance strategies, and discount options for 2026.
How veterans can access compounded enclomiphene citrate through the VA healthcare system, including formulary status, nonformulary request steps, cost comparisons, and alternative coverage options.
A practical guide to accessing epitalon tetrapeptide at reduced cost, including compounding pharmacy options, patient assistance alternatives, and what insurance does (and does not) cover in 2026.
A clinical guide to accessing epitalon tetrapeptide through VA benefits, compounding pharmacies, and cost-reduction strategies for veterans in 2026.
How Medicare Advantage plans cover estradiol transdermal patches (Climara, Vivelle-Dot, Minivelle), what you will pay, and practical strategies to lower your out-of-pocket cost in 2026.
Find out whether Medicare Part D covers estradiol patches like Climara and Vivelle-Dot, what you'll pay at the pharmacy, and how to cut your out-of-pocket costs in 2026.
A complete guide to the Repatha (evolocumab) manufacturer copay program from Amgen, including eligibility, savings amounts, insurance tips, and alternative ways to reduce your cost.
How Medicare Part D covers Repatha (evolocumab), what you will actually pay, manufacturer copay cards, patient assistance programs, and step-by-step strategies to lower your out-of-pocket cost in 2026.
A complete guide to Repatha (evolocumab) patient assistance programs, copay cards, manufacturer support, and insurance strategies for low-income patients in 2026.
A clinical guide to compounded finasteride formulations, generic pricing, insurance coverage, manufacturer coupons, and strategies to access finasteride at the lowest possible cost in 2026.
Learn how to access finasteride manufacturer copay cards, patient assistance programs, and insurance coverage options to reduce your out-of-pocket cost for hair loss and BPH treatment.
Compounded flibanserin offers a fraction of Addyi's $880 cash price. Learn how compounding pharmacies, manufacturer coupons, and insurance options can make HSDD treatment accessible.
GHK-Cu has no traditional manufacturer copay program because it is a compounded peptide. Learn how 503A pharmacy pricing, telehealth platforms, and patient-assistance workarounds can cut your out-of-pocket cost for copper tripeptide GHK-Cu.
GHK-Cu is not covered by Medicare Advantage plans. Learn why copper tripeptide GHK-Cu falls outside Medicare formularies, what it costs out of pocket, and how to reduce your spending on this compounded peptide.